NASDAQ:GLYC
Delisted

Glycomimetics Stock Signals

etoro logo Buy GLYC
*Your capital is at risk
$15.71
+0 (+0%)
At Close: Oct 01, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for GlycoMimetics

General

Signal Type Signal Value Data
Score 0.000 68 days ( 8.10 %
Last Price $15.71 0 %
Performance History
7 Days
$15.71 $15.71
0%
30 Days
$15.71 $15.71
0%
12 Mos
$0.166 $15.71
9,372.26%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $15.71 - $15.71
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Sep 30, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Aug 12, 2025 - 36 days
Short/Long MA 3 mos Sell Medium Aug 12, 2025 - 36 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.75
Signal Type Signal Value Importance Data
Trend - 12 mos 419.36 % Very High Width: 299.88 %
Pred. range - 12 mos $29.71 - $118.80 High 89.16 % - 656.43 %
Short MA 12 mos Sell Very High Jul 23, 2025 - 50 days
Long MA 12 mos Buy Very High Jun 24, 2025 - 70 days
Short/Long MA 12 mos Buy Very High Jun 24, 2025 - 70 days
Pivot Long Buy Low Jul 02, 2025 - 64 days
RSI Long Pivot Signal Sell Low Jun 25, 2025 - 69 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GLYCOMIMETICS
GlycoMimetics
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE